Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pei Tu Qing Xin is a Traditional Chinese Medicine (TCM) herbal formula developed and primarily investigated by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of atopic dermatitis, particularly in pediatric patients. The formula is based on the TCM therapeutic principle of "strengthening the earth (Spleen) and clearing the heart," which aims to address the systemic imbalances of dampness and heat believed to drive skin inflammation. Clinical research, including trials registered under ChiCTR1800014317, has focused on its efficacy in improving skin lesions (as measured by the SCORAD index) and its regulatory effects on the intestinal microbiota, suggesting a mechanism of action involving the gut-skin axis. It is typically administered orally as a decoction or in concentrated granule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pei Tu Qing Xin.